BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 25282488)

  • 1. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
    Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD; Motta I
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-thalassemia intermedia: a clinical perspective.
    Musallam KM; Taher AT; Rachmilewitz EA
    Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
    Abdulwahid DA; Hassan MK
    Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalassemia Intermedia: Chelator or Not?
    Lee YC; Yen CT; Lee YL; Chen RJ
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
    Cappellini MD; Musallam KM; Taher AT
    Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary hematopoiesis-related pleural effusion: the case of beta-thalassemia.
    Aessopos A; Tassiopoulos S; Farmakis D; Moyssakis I; Kati M; Polonifi K; Tsironi M
    Ann Thorac Surg; 2006 Jun; 81(6):2037-43. PubMed ID: 16731126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approaches to treatment of beta-thalassemia intermedia.
    Taher AT; Musallam KM; Karimi M; Cappellini MD
    Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
    Cario H; Wegener M; Debatin KM; Kohne E
    Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidities in non-transfusion-dependent thalassemia.
    Saliba AN; Taher AT
    Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-thalassemia.
    Rund D; Rachmilewitz E
    N Engl J Med; 2005 Sep; 353(11):1135-46. PubMed ID: 16162884
    [No Abstract]   [Full Text] [Related]  

  • 16. An update on thalassemia intermedia.
    Maakaron JE; Cappellini MD; Taher AT
    J Med Liban; 2013; 61(3):175-82. PubMed ID: 24422369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM; Cappellini MD; Taher AT
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
    Karimi M; Cohan N; De Sanctis V; Mallat NS; Taher A
    Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.